Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 2 days 22 hours ago
AstraZeneca Caps US Inhaler Out-of-Pocket Costs on Heels of Boehringer
AstraZeneca Caps US Inhaler Out-of-Pocket Costs on Heels of Boehringer 3/18/2024
Madrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies
Madrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies 3/18/2024
FDA Action Alert: Orchard, ITF, Merck and More
FDA Action Alert: Orchard, ITF, Merck and More 3/18/2024
Opinion: I Know I Want to Implement AI in My Company’s R&D. What Now?
Opinion: I Know I Want to Implement AI in My Company’s R&D. What Now? 3/18/2024
FDA Adcomm Backs J&J’s Carvykti, BMS’s Abecma Early in Multiple Myeloma
FDA Adcomm Backs J&J’s Carvykti, BMS’s Abecma Early in Multiple Myeloma 3/15/2024
Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data
Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data 3/15/2024
Biotheus, Hansoh Expand Partnership in $694M ADC Deal
Biotheus, Hansoh Expand Partnership in $694M ADC Deal 3/15/2024
Astellas Backs Out of Potential $340M Licensing Deal with Cartesian
Astellas Backs Out of Potential $340M Licensing Deal with Cartesian 3/15/2024
Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets
Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets 3/15/2024
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer 3/15/2024
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia 3/15/2024
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma 3/15/2024
NASH or MASH: No Matter What You Call It, Madrigal’s FDA Approval Is a Big Deal
NASH or MASH: No Matter What You Call It, Madrigal’s FDA Approval Is a Big Deal 3/15/2024
BeiGene’s Tevimbra Wins First US Approval Following Tough Regulatory Path
BeiGene’s Tevimbra Wins First US Approval Following Tough Regulatory Path 3/15/2024
FDA Adcomm Backs Geron’s Anemia Drug for Blood Cancer
FDA Adcomm Backs Geron’s Anemia Drug for Blood Cancer 3/15/2024
FDA Approves Madrigal’s Rezdiffra as First MASH Therapy
FDA Approves Madrigal’s Rezdiffra as First MASH Therapy 3/15/2024
AstraZeneca Boosts Rare Disease Portfolio with $1.05B Amolyt Acquisition
AstraZeneca Boosts Rare Disease Portfolio with $1.05B Amolyt Acquisition 3/14/2024
BIO Boots WuXi AppTec from Trade Group Amid US National Security Concerns
BIO Boots WuXi AppTec from Trade Group Amid US National Security Concerns 3/14/2024
ADC Biotech Tubulis Closes Upsized $138M Financing Round
ADC Biotech Tubulis Closes Upsized $138M Financing Round 3/14/2024
Recently Laid Off? Contract Work Could Be an Attractive Option
Recently Laid Off? Contract Work Could Be an Attractive Option 3/14/2024
World Pharma News
- Possible alternative to antibiotics produced by bacteria
- Kaposi sarcoma discovery could facilitate drug development
- Healthy lifestyle may offset effects of life-shortening genes by 60%+
- U.S. FDA approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a one-time gene therapy for adults with Hemophilia B
- AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure